Cardiovascular disease in women with polycystic ovary syndrome at long- term follow-up: A retrospective cohort study

Clinical Endocrinology

Volumn 52, Issue 5, 2000, Pages 595-600

  Wild, Sarah ^a,c   Pierpoint, Tracey ^a   McKeigue, Paul ^a   Jacobs, Howard ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; OVARY POLYCYSTIC DISEASE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0034078044     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2000.01000.x     Document Type: Article

References (17)

1. Balen, A.H., Conway, G.S., Kaltsas, G., Techatrasak, K., Manning, P.J., West, C. & Jacobs, H.S. (1995) Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Human Reproduction, 10, 2107-2111.
2. Burghen, G.A., Givens, J.R. & Kitabchi, A.E. (1980) Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. Journal of Clinical Endocrinology and Metabolism, 50, 113-116.
3. Clayton, R.N., Ogden, V., Hodgkinson, J., Worswick, L., Rodin, D.A., Dyer, S. & Meade, T.W. (1992) How common are polycystic ovaries in normal women and what is their significance for the fertility of the population? Clinical Endocrinology, 37, 127-134.
4. Conway, G.S., Agrawal, R., Betteridge, D.J. & Jacobs, H.S. (1992) Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clinical Endocrinology, 37, 119-125.
5. Conway, G.S., Jacobs, H.S., Holly, J.M. & Wass, J.A. (1990) Effects of luteinizing hormone, insulin, insulin-like growth factor-1 and insulin-like growth factor small binding protein 1 in the polycystic ovary syndrome. Clinical Endocrinology, 33, 593-603.
6. Dahlgren, E., Janson, P.O., Johansson, S., Lapidus, L. & Oden, A. (1992a) Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women. Acta Obstetrica Gynecologica Scandinavica, 71, 599-604.
7. Dahlgren, E., Johansson, S., Lindstedt, G., Knutsson, F., Oden, A., Janson, P.O., Mattsson, L.A., Crona, N. & Lundberg, P.A. (1992b) Women with polycystic ovary syndrome wedge resected in 1956-65: a long-term follow-up focusing on natural history and circulating hormones. Fertility and Sterility, 57, 505-513.
8. Dunaif, A. (1995) Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of noninsulin-dependent diabetes mellitus. American Journal of Medicine, 98, 33S-39S.
9. James, R. & Givens, M.D. (1979) Pathogenesis of polycystic ovarian disease. Acta Europaea Fertilitatis, 10, 89-103.
10. Legro, R.S., Coleman, K.H., Irwin, L., Dunaif, A. & Dodson, W.C. (1995) Polycystic ovary syndrome over age 40: age related differences in phenotype [Abstract P370]. Journal of the Society of Gynecological Investigation, 2, 401-401 (Abstract).
11. Pierpoint, T., McKeigue, P.M., Isaacs, A.J., Wild, S.H. & Jacobs, H.S. (1998) Mortality of women with polycystic ovary syndrome at long-term follow-up. Journal of Clinical Epidemiology, 51, 581-586.
12. Polson, D.W., Adams, J., Wadsworth, J. & Franks, S. (1988) Polycystic ovaries - a common finding in normal women. Lancet, 1, 870-872.
13. Robinson, S., Kiddy, D., Gelding, S.V., Willis, D., Niththyananthan, R., Bush, A., Johnston, D.G. & Franks, S. (1993) The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries. Clinical Endocrinology, 39, 351-355.
14. Stein, I.F. & Leventhal, M.L. (1935) Amenorrhea associated with bilateral polycystic ovaries. American Journal of Obstetrics and Gynecology, 29, 181-187.
15. Talbott, E., Clerici, A., Berga, S.L., Kuller, L., Guzick, D., Detre, K., Daniels, T. & Engberg, R.A. (1998) Adverse lipid and coronary heart disease risk factors in young women with polycystic ovary syndrome: results of a case-control study. Journal of Clinical Epidemiology, 51, 415-422.
16. Talbott, E., Guzick, D., Clerici, A., Berga, S., Detre, K., Weimer, K. & Kuller, L. (1995) Coronary heart disease risk factors in women with polycystic ovary syndrome. Arteriosclerosis, Thrombosis and Vascular Biology, 15, 821-826.
17. Wild, R.A., Painter, P.C., Coulson, P.B., Carruth, K.B. & Ranney, G.B. (1985) Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism, 61, 946-951.